Inducers of cross-linked actin networks in trabecular meshwork cells

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7316-7324

  O'Reilly, Steven ^a   Pollock, Natalie ^a   Currie, Laura ^a   Paraoan, Luminita ^a   Clark, Abbot F ^b   Grierson, Ian ^a,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DECORIN; DEXAMETHASONE; TRANSFORMING GROWTH FACTOR BETA2; PROTEIN SERINE THREONINE KINASE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; COW; FETAL CALF SERUM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; TRABECULAR MESHWORK; WESTERN BLOTTING; ANIMAL; CATTLE; CELL CULTURE; CONFOCAL MICROSCOPY; CYTOSKELETON; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ACTINS; ANIMALS; AQUEOUS HUMOR; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; CYTOSKELETON; DECORIN; MICROSCOPY, CONFOCAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84856377276     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6692     Document Type: Article

References (59)

1. Wiederholt M. Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow. Curr Opin Ophthalmol. 1998;9:46-49.
2. Wiederholt M, Thieme H, Stumpff F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res. 2000;19:271-295.
3. Ferrer E. Trabecular meshwork as a new target for the treatment of glaucoma. Drug News Perspect. 2006;19:151-158.
4. Tian B, Gabelt BT, Geiger B, Kaufman PL. The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res. 2009;88:713-717.
5. Grierson I, Rahi AHS. Microfilaments in the cells of the human trabecular meshwork. Br J Ophthalmol. 1979;63:3-8.
6. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40: 74-81.
7. Read AT, Chan DW, Ethier CR. Actin structure in the outflow tract of normal and glaucomatous eyes. Exp Eye Res. 2006;82:974-985.
8. Hogg PA, Davies H, Grierson J. Melanin phagocytosis by the cells of the trabecular meshwork: a mechanism for cell loss in ageing and glaucoma? Invest Ophthalmol Vis Sci. 1996;37:1905-1905.
9. Zhou L, Li Y, Yue BY. Alteration of cytoskeletal structure, integrin distribution, and migratory activity by phagocytic challenge in cells from an ocular tissue-the trabecular meshwork. In Vitro Cell Dev Biol Anim. 1999;35:144-149.
10. Zhang XY, Ognibene CM, Clark AF, Yorio T. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta. Exp Eye Res. 2007;84: 275-284.
11. Grierson I, Hogg P. The proliferative and migratory activities of trabecular meshwork cells. Prog Retin Eye Res. 1995;15:33-67.
12. Zhou LL, Li YH, Yue BYJT. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J Cell Physiol. 1999;180:182-189.
13. Koga T, Koga T, Awai M, Tsutsui JI, Yue BYJT, Tanihara H. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells. Exp Eye Res. 2006;82:362-370.
14. Tumminia SJ, Mitton KP, Arora J, Zelenka P, Epstein DL, Russell P. Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:1361-1371.
15. Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41:619-623.
16. Goldmann H. Cortisone glaucoma. Arch Ophthalmol. 1962;68: 621-626.
17. Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs Aging. 1999;15:439-450.
18. Jones R 3rd, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17:163-167.
19. Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88:752-759.
20. Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature. Eye. 2006;20:407-416.
21. Grierson I, Millar L, Deyong J, et al. Investigations of cytoskeletal elements in cultured bovine meshwork cells. Invest Ophthalmol Vis Sci. 1986;27:1318-1330.
22. Clark AF, Brotchie D, Read AT, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005;60:83-95.
23. Hoare MJ, Grierson I, Brotchie D, Pollock N, Cracknell K, Clark AF. Cross-linked actin networks (CLANs) in the trabecular meshwork of the normal and glaucomatous human eye in situ. Invest Ophthalmol Vis Sci. 2009;50:1255-1263.
24. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294.
25. Wade NC, Grierson I, O'Reilly S, et al. Cross-linked actin networks (CLANs) in bovine trabecular meshwork cells. Exp Eye Res. 2009;89:648-659.
26. Filla MS, Schwinn MK, Nosie AK, Clark RW, Peters DM. Dexamethasone-associated cross-linked actin network formation in human trabecular meshwork cells involves β3 integrin signaling. Invest Ophthalmol Vis Sci. 2011;52:2952-2959.
27. Clark AF, Miggans ST, Wilson K, Browder S, McCartney MD. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J Glaucoma. 1995;4:183-188.
28. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994;59:723-727.
29. Agarwal R, Agarwal P. Future target molecules in antiglaucoma therapy: TGF-beta may have a role to play. Ophthalmic Res. 2010;43:1-10.
30. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86:543-561.
31. Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 2005;24:612-637.
32. Knepper PA, Goossens W, Hvizd M, Palmberg PF. Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1360-1367.
33. Ishibashi T, Takagi Y, Mori K, et al. cDNA microarray analysis of gene expression changes induced by dexamethasone in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2002;43:3691-3697.
34. Grierson I, Robins E, Unger W, Millar L, Ahmed A. The cells of the bovine outflow system in tissue culture. Exp Eye Res. 1985;40:35-46.
35. Pang IH, Shade DL, Clark AF, Steely HT, DeSantis L. Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res. 1994;13:51-63.
36. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-beta in human aqueous humor. Curr Eye Res. 1990;9:963-969.
37. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201-2211.
38. Freddo TF. The Glenn A. Fry Award Lecture 1992: aqueous humor proteins: a key for unlocking glaucoma? Optom Vis Sci. 1993;70: 263-270.
39. Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res. 2004;79:677-688.
40. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor beta: biological function and chemical structure. Science. 1986;233:532-534.
41. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TGF beta 2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006;47:226-234.
42. Zhao XJ, Ramsey KE, Stephan DA, Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci. 2004;45:4023-4034.
43. Yamamoto N, Itonaga K, Marunouchi T, Majima K. Concentration of transforming growth factor 2 in aqueous humor. Ophthalmic Res. 2005;37:29-33.
44. Fanger BO, Wakefield LM, Sporn MB. Structure and properties of the cellular receptor for transforming growth factor type beta. Biochemistry. 1986;25:3083-3091.
45. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
46. Tripathi RC, Borisuth NSC, Kolli SP, Tripathi BJ. Trabecular cells express receptors that bind TGF-beta-1 and TGF-beta-2: a qualitative and quantitative characterization. Invest Ophthalmol Vis Sci. 1993;34:260-263.
47. Wordinger RJ, Clark AF, Agarwal R, et al. Cultured human trabecular meshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci. 1998;39:1575-1589.
48. Xiao YQ, Liu K, Shen JF, Xu GT, Ye W. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol Vis Sci. 2009;50:1698-1706.
49. Singh J, Ling LE, Sawyer JS, Lee WC, Zhang FM, Yingling JM. Transforming the TGF beta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for T beta RI (ALK5). Curr Opin Drug Disc. 2004;7:437-445.
50. Clark AF, Lane D, Wilson K, Miggans ST, McCartney MD. Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1996;37:805-813.
51. Tripathi RC, Millard CB, Tripathi BJ. Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples. Exp Eye Res. 1989;48:117-130.
52. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346:281-284.
53. Logan A, Baird A, Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol. 1999;159:504-510.
54. Grisanti S, Szurman P, Warga M, et al. Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study. Invest Ophthalmol Vis Sci. 2005;46:191-196.
55. Filla MS, Woods A, Kaufman PL, Peters DM. Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:1956-1967.
56. Hernandez MR, Weinstein BI, Dunn MW, Gordon GG, Southren AL. The effect of dexamethasone on the synthesis of collagen in normal human trabecular meshwork explants. Invest Ophthalmol Vis Sci. 1985;26:1784-1788.
57. Wilson K, McCartney MD, Miggans ST, Clark AF. Dexamethasoneinduced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res. 1993;12:783-793.
58. Merle B, Durussel L, Delmas PD, Clezardin P. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem. 1999;75:538-546.
59. Fautsch MP, Howell KG, Vrabel AM, Charlesworth MC, Muddiman DC, Johnson DH. Primary trabecular meshwork cells incubated in human aqueous humor differ from cells incubated in serum supplements. Invest Ophthalmol Vis Sci. 2005;46:2848-2856.